Medigen Vaccine Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 3, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	11,720	11,851	23,035	22,785	63,653	21,743
Market Cap Growth	-31.44%	-48.55%	1.10%	-64.20%	192.75%	388.97%
Enterprise Value	10,345	10,382	21,271	20,540	62,660	22,145
Last Close Price	35.65	36.05	70.10	69.50	200.91	69.21
PE Ratio	-	-	-	-	45.14	-
PS Ratio	19.70	19.57	59.12	62.42	19.40	1889.56
PB Ratio	3.25	3.08	5.99	4.53	13.61	6.92
P/TBV Ratio	3.27	3.10	6.05	4.57	13.77	7.06
P/FCF Ratio	-	1835.64	-	-	142.64	-
P/OCF Ratio	488.29	290.80	-	-	109.77	-
EV/Sales Ratio	17.39	17.14	54.59	56.27	19.10	1924.50
EV/EBITDA Ratio	-	-	-	-	58.45	-
EV/EBIT Ratio	-	-	-	-	65.02	-
EV/FCF Ratio	-365.72	1608.05	-	-	140.41	-
Debt / Equity Ratio	0.08	0.09	0.51	0.39	0.04	0.06
Debt / EBITDA Ratio	-	-	-	-	0.17	-
Debt / FCF Ratio	-	52.50	-	-	0.42	-
Net Debt / Equity Ratio	-0.38	-0.41	-0.46	-0.45	-0.44	-0.49
Net Debt / EBITDA Ratio	29.18	60.26	1.62	1.60	-1.91	2.36
Net Debt / FCF Ratio	48.62	-244.21	3.42	1.69	-4.59	2.24
Asset Turnover	0.14	0.12	0.06	0.06	0.75	0.00
Inventory Turnover	0.58	0.50	0.25	0.76	2.84	0.09
Quick Ratio	10.98	9.54	1.99	12.48	6.54	11.58
Current Ratio	14.12	11.94	2.21	15.38	8.48	12.48
Return on Equity (ROE)	-4.44%	-2.09%	-26.14%	-30.39%	36.08%	-29.91%
Return on Assets (ROA)	-2.50%	-1.74%	-11.29%	-15.18%	13.71%	-16.55%
Return on Capital Employed (ROCE)	-4.30%	-3.50%	-29.60%	-22.00%	19.80%	-22.90%
Earnings Yield	-1.41%	-0.68%	-5.04%	-6.47%	2.22%	-3.10%
FCF Yield	-0.24%	0.05%	-2.26%	-5.94%	0.70%	-3.17%
Buyback Yield / Dilution	-0.01%	-0.10%	-1.50%	-0.73%	-15.82%	-20.08%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.